Osteonecrosis of the jaw.
Reilly
Margaret M
MM
New York University Clinical Cancer Center New York, New York, USA.
Moore
Susan
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000473:pathology; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D007571:Jaw Diseases / Q000145:classification / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged; D010020:Osteonecrosis / Q000145:classification / Q000188:drug therapy / Q000209:etiology*; D010404:Penicillin V / Q000627:therapeutic use; D012307:Risk Factors; D014081:Tooth Extraction; D000077211:Zoledronic Acid
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D010404:Penicillin V